Search research articles
Contact Us
Filters
Showing results (481-490 of 761) with videos related to
Page
of 77
Sort By:
Circulation
|
June 17, 2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study
Marco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
Circulation
|
October 6, 2005
Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial
Manel Sabaté, Pilar Jiménez-Quevedo, Dominick J Angiolillo, et al.
European Heart Journal
|
June 15, 2007
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial
Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.
European Heart Journal
|
July 11, 2025
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
Giovanni Occhipinti, Claudio Laudani, Mattia Galli, et al.
Journal of the American Heart Association
|
September 25, 2019
Three-Dimensional Echocardiography for Transcatheter Aortic Valve Replacement Sizing: A Systematic Review and Meta-Analysis
Lisa Q Rong, Irbaz Hameed, Arash Salemi, et al.
JACC. Cardiovascular Interventions
|
February 11, 2022
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes
Claudio Laudani, Antonio Greco, Giovanni Occhipinti, et al.
Circulation
|
October 7, 2009
Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts
Javier Escaned, Alex Flores, Pablo García-Pavía, et al.
The American Journal of Cardiology
|
January 8, 2011
Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation
Roberta Rossini, Davide Capodanno, Corrado Lettieri, et al.
Journal of Thrombosis and Thrombolysis
|
May 10, 2012
Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
Dominick J Angiolillo, David J Schneider, Deepak L Bhatt, et al.
Journal of Thrombosis and Thrombolysis
|
November 28, 2012
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation
José L Ferreiro, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Page
of 77
Search research articles
Search
Showing results (481-490 of 761) with videos related to
Sort By:
Page
of 77
Circulation
|
June 17, 2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study
Marco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
Circulation
|
October 6, 2005
Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial
Manel Sabaté, Pilar Jiménez-Quevedo, Dominick J Angiolillo, et al.
European Heart Journal
|
June 15, 2007
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial
Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.
European Heart Journal
|
July 11, 2025
Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
Giovanni Occhipinti, Claudio Laudani, Mattia Galli, et al.
Journal of the American Heart Association
|
September 25, 2019
Three-Dimensional Echocardiography for Transcatheter Aortic Valve Replacement Sizing: A Systematic Review and Meta-Analysis
Lisa Q Rong, Irbaz Hameed, Arash Salemi, et al.
JACC. Cardiovascular Interventions
|
February 11, 2022
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes
Claudio Laudani, Antonio Greco, Giovanni Occhipinti, et al.
Circulation
|
October 7, 2009
Assessment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements: validation with endomyocardial sampling in cardiac allografts
Javier Escaned, Alex Flores, Pablo García-Pavía, et al.
The American Journal of Cardiology
|
January 8, 2011
Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation
Roberta Rossini, Davide Capodanno, Corrado Lettieri, et al.
Journal of Thrombosis and Thrombolysis
|
May 10, 2012
Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials
Dominick J Angiolillo, David J Schneider, Deepak L Bhatt, et al.
Journal of Thrombosis and Thrombolysis
|
November 28, 2012
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation
José L Ferreiro, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Page
of 77